Sealonix
Bedford, US · Founded 2023 · Delaware corporation · 2 known investors
Sealonix develops hemostatic sealants based on proprietary biomaterials to control surgical bleeding, targeting surgeons and patients undergoing abdominopelvic and other surgical procedures. Its initial product, the PramStat patch, is an experimental sealant patch for rapid hemostasis during surgery.
BiotechMedical DevicesNew Materials
Founders & leadership
AS
Amarpreet SawhneyExecutive Officer, Director
AS
Amar SawhneyFounder
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$19.6MraisedMay 2023 · 26 investors · OtherRule 506(b)
▶$19.6MraisedMay 2023 · 26 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Amarpreet SawhneyExecutive Officer, Director
- Offering amount
- $20.1M
- Amount sold
- $19.6M
- Minimum investment
- $20K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.